Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection

Ann Intern Med. 2021 Mar;174(3):I16. doi: 10.7326/P20-0015. Epub 2020 Dec 8.
No abstract available

Publication types

  • Patient Education Handout

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • COVID-19 / diagnosis
  • COVID-19 / prevention & control*
  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine / adverse effects
  • Hydroxychloroquine / therapeutic use*
  • Post-Exposure Prophylaxis*
  • SARS-CoV-2
  • Time Factors
  • Treatment Outcome
  • United States

Substances

  • Antiviral Agents
  • Hydroxychloroquine